Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05940077 · ClinicalTrials.gov registry record · NA

Community Exercise for Fall Risk in PD

A NA study of Parkinson Disease and Exercise, sponsored by Idaho State University.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT05940077 is a NA study of Parkinson Disease and Exercise that has completed, run by Idaho State University. The registered enrollment target is 20 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05940077, a NA study of Parkinson Disease and Exercise, has completed, sponsored by Idaho State University.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Parkinson's disease (PD) affects approximately 1 million people in the United States and causes significant fall risks. This study aims to develop a community-based exercise program that reduces falls in persons with PD. By combining individualized balance activities with group boxing training, the study seeks to identify modifiable risk factors, improve balance dysfunction, and reduce falls. The findings will inform clinical practice, offering a community-based exercise model to address the urgent need for effective fall prevention interventions in PD.

Interventions

  • BEHAVIORAL Exercise

Study Locations (1)

Idaho

  • Idaho State University - Pocatello

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2020-07-15
Est. Completion 2022-03-30
Phase NA

Sponsor

Idaho State University

8 total trials

What the Registry Record Tells You About NCT05940077

The ClinicalTrials.gov registry entry for NCT05940077 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The listed sponsor is Idaho State University, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Exercise is the first listed.

NCT05940077 reports 1 study location spanning 1 distinct geographic area - top geographies include Idaho.

Frequently Asked Questions

What is clinical trial NCT05940077 about?

NCT05940077 is a clinical study titled "Community Exercise for Fall Risk in PD". Parkinson's disease (PD) affects approximately 1 million people in the United States and causes significant fall risks. This study aims to develop a community-based exercise program that reduces falls in persons with PD. By combining individualized balance activities with group boxing training, the ...

What is the current status of trial NCT05940077?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2020-07-15. Estimated completion is 2022-03-30.

What conditions does trial NCT05940077 study?

This clinical trial studies the following conditions: Parkinson Disease, Exercise, Fall.

What interventions are being tested in trial NCT05940077?

The interventions under investigation include: Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT05940077?

This trial is sponsored by Idaho State University, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05940077 being conducted?

This trial has 1 study location across Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.